Get the Stockscreener App
26.56
1.14%
0.30
Procept Biorobotics Corp stock is traded at $26.56, with a volume of 1.31M.
It is up +1.14% in the last 24 hours and down -8.19% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$26.26
Open:
$26.48
24h Volume:
1.31M
Relative Volume:
0.88
Market Cap:
$1.48B
Revenue:
$249.12M
Net Income/Loss:
$-90.19M
P/E Ratio:
-15.62
EPS:
-1.7
Net Cash Flow:
$-88.21M
1W Performance:
-4.60%
1M Performance:
-8.19%
6M Performance:
-30.73%
1Y Performance:
-59.13%
1-Day Range:
$26.11
$27.08
1-Week Range:
$19.35
$27.08
52-Week Range:
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
26.56 | 1.47B | 249.12M | -90.19M | -88.21M | -1.70 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
Procept BioRobotics Balances Rapid Growth With Profit Push - TipRanks
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $19.35 - Markets Mojo
PROCEPT BioRobotics Stock Hits Day Low of $19.35 Amid Price Pressure - Markets Mojo
PROCEPT BioRobotics Faces Weak Start with 30.5% Gap Down Amid Market Concerns - Markets Mojo
Mitsubishi UFJ Asset Management Co. Ltd. Sells 56,967 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Champlain Investment Partners LLC Grows Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Citigroup Inc. Purchases 45,979 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects - 富途牛牛
PROCEPT BioRobotics (+14%): Cowen Conference Rebound After Earnings Sell-Off - Trefis
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics CorporationPRCT - ChartMill
PROCEPT BioRobotics Corporation (PRCT) Investor Outlook: Unveiling the 23.55% Potential Upside in Healthcare Robotics - DirectorsTalk Interviews
William Blair Investment Management LLC Purchases 54,396 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Vanguard Group Inc. Sells 42,630 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Procept BioRobotics price target lowered to $30 from $47 at Truist - Yahoo Finance
PRCT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Procept BioRobotics at TD Cowen Conference: Strategic Growth Focus - Investing.com
PROCEPT BioRobotics (NASDAQ:PRCT) Stock Price Up 9.9%Here's Why - MarketBeat
JPMorgan Chase & Co. Cuts Stake in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Cowen Maintains Buy on PRCT PROCEPT BioRobotics Corporation Feb 2026 - Meyka
PRCT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PROCEPT BioRobotics (PRCT) Is Down 16.8% After Cutting 2026 Outlook And Widening Q4 Losses - simplywall.st
PROCEPT BioRobotics Investor Day: 2026 growth targets, higher ASPs, and profitability roadmap - Yahoo Finance
A Look At PROCEPT BioRobotics (PRCT) Valuation After Q4 Revenue Miss And Softer 2026 Outlook - Yahoo Finance
PROCEPT BioRobotics Corporation (PRCT) Competitors - Meyka
Artisan Partners Limited Partnership Buys 378,844 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Resets Commercial Model To Pursue Higher Quality Growth - simplywall.st
PRCT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PRCT Should I Buy - Intellectia AI
Truist cuts Procept BioRobotics stock price target on lower forecasts By Investing.com - Investing.com Australia
Truist cuts Procept BioRobotics stock price target on lower forecasts - Investing.com
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Lowered to Hold at Jefferies Financial Group - MarketBeat
PROCEPT BioRobotics Corporation (PRCT) Analyst/Investor DaySlideshow (NASDAQ:PRCT) 2026-02-27 - Seeking Alpha
PROCEPT BioRobotics (PRCT) Quarterly Loss Deepens Challenging Bullish Margin Expansion Narrative - simplywall.st
Ademi LLP Investigates Claims of Securities Fraud against PROCEPT BioRobotics Corporation - PR Newswire
PROCEPT BioRobotics Corporation (PRCT) Releases Q4 2025 Earnings: Revenue Growth but Continued Losses - Quiver Quantitative
TD Cowen reiterates Procept BioRobotics stock rating at Buy By Investing.com - Investing.com India
Robotics Play Procept Biorobotics Plummets On Hard-To-Stomach Update - Investor's Business Daily
Leerink Partners Cuts PROCEPT BioRobotics (NASDAQ:PRCT) Price Target to $30.00 - MarketBeat
PROCEPT BioRobotics : 2026 Investor Day Presentation - marketscreener.com
PROCEPT BioRobotics (NASDAQ:PRCT) Given New $34.00 Price Target at TD Cowen - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Price Target Cut to $28.00 by Analysts at Piper Sandler - MarketBeat
PROCEPT BioRobotics Corporation (PRCT): Analysts Downgrade to Underperform Amid Persistent Stock Struggles - 富途牛牛
Procept Biorobotics Corporation Provides Financial Guidance for the Year 2027 - marketscreener.com
PROCEPT BioRobotics (NASDAQ:PRCT) Reaches New 1-Year Low After Earnings Miss - MarketBeat
Procept BioRobotics sees FY26 revenue growth 27%-33% - TipRanks
Oppenheimer Downgrades PROCEPT BioRobotics to Perform From Outperform, Removes $60 Price Target - marketscreener.com
Oppenheimer Downgrades PROCEPT BioRobotics(PRCT.US) to Hold Rating, Maintains Target Price $60 - 富途牛牛
Procept BioRobotics price target lowered to $34 from $51 at Wells Fargo - TipRanks
Procept BioRobotics price target lowered to $28 from $50 at Piper Sandler - TipRanks
Piper Sandler cuts Procept BioRobotics price target on weak Q4 - Investing.com Nigeria
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):